Certain Shares of Egetis Therapeutics AB are subject to a Lock-Up Agreement Ending on 13-NOV-2022.
Details:
Shareholding members of the Board of Directors and management of the Company will undertake, subject to customary exceptions, not to sell shares in the Company for a period of 180 days from settlement of the Rights Issue.